{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:40:49Z","timestamp":1793936449243,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS092667"],"award-info":[{"award-number":["1R01NS092667"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG060195"],"award-info":[{"award-number":["R01AG060195"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010368"],"award-info":[{"award-number":["W81XWH2010368"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010371"],"award-info":[{"award-number":["W81XWH2010371"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Consolidated Anti-Aging Foundation"},{"name":"The Orchard Foundation"},{"name":"Harold and Ronna Cooper Post-Doctoral Fellowship for Parkinson\u2019s Disease Research"},{"name":"Parkinson's UK"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Society Wolfson Research Merit"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sandhoff disease (SD) is a lysosomal storage disease, caused by loss of \u03b2-hexosaminidase (HEX) activity resulting in the accumulation of ganglioside GM2. There are shared features between SD and Parkinson\u2019s disease (PD). \u03b1-synuclein (aSYN) inclusions, the diagnostic hallmark sign of PD, are frequently found in the brain in SD patients and HEX knockout mice, and HEX activity is reduced in the substantia nigra in PD. In this study, we biochemically demonstrate that HEX deficiency in mice causes formation of high-molecular weight (HMW) aSYN and ubiquitin in the brain. As expected from HEX enzymatic function requirements, overexpression in vivo of HEXA and B combined, but not either of the subunits expressed alone, increased HEX activity as evidenced by histochemical assays. Biochemically, such HEX gene expression resulted in increased conversion of GM2 to its breakdown product GM3. In a neurodegenerative model of overexpression of aSYN in rats, increasing HEX activity by AAV6 gene transfer in the substantia nigra reduced aSYN embedding in lipid compartments and rescued dopaminergic neurons from degeneration. Overall, these data are consistent with a paradigm shift where lipid abnormalities are central to or preceding protein changes typically associated with PD.<\/jats:p>","DOI":"10.1186\/s40478-020-01004-6","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:02:57Z","timestamp":1596711777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Upregulating \u03b2-hexosaminidase activity in rodents prevents \u03b1-synuclein lipid associations and protects dopaminergic neurons from \u03b1-synuclein-mediated neurotoxicity"],"prefix":"10.1186","volume":"8","author":[{"given":"Oeystein R.","family":"Brekk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Korecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile C.","family":"Crapart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylene","family":"Huebecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary K.","family":"MacBain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ann","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Priestman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-9096","authenticated-orcid":false,"given":"Penelope J.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1247\/csf.14.561","volume":"14","author":"H Asou","year":"1989","unstructured":"Asou H, Hirano S, Uyemura K (1989) Ganglioside composition of astrocytes. Cell Struct Funct 14:561\u2013568. https:\/\/doi.org\/10.1247\/csf.14.561","journal-title":"Cell Struct Funct"},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/258262a0","volume":"258","author":"E Beutler","year":"1975","unstructured":"Beutler E, Kuhl W (1975) Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes. Nature 258:262\u2013264. https:\/\/doi.org\/10.1038\/258262a0","journal-title":"Nature"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.cdd.4402013","volume":"14","author":"P Bifsha","year":"2007","unstructured":"Bifsha P, Landry K, Ashmarina L, Durand S, Seyrantepe V, Trudel S, Quiniou C, Chemtob S, Xu Y, Gravel RA, Sladek R, Pshezhetsky AV (2007) Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway. Cell Death Differ 14:511\u2013523. https:\/\/doi.org\/10.1038\/sj.cdd.4402013","journal-title":"Cell Death Differ"},{"key":"1004_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194\u2013202. https:\/\/doi.org\/10.1016\/j.tins.2007.03.006","journal-title":"Trends Neurosci"},{"key":"1004_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/0192623310385140","volume":"38","author":"RW Boyce","year":"2010","unstructured":"Boyce RW, Dorph-Petersen K-A, Lyck L, Gundersen HJG (2010) Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol 38:1011\u20131025. https:\/\/doi.org\/10.1177\/0192623310385140","journal-title":"Toxicol Pathol"},{"key":"1004_CR6","doi-asserted-by":"publisher","unstructured":"Breiden B, Sandhoff K (2019) Lysosomal Glycosphingolipid Storage Diseases. Annu Rev Biochem 88:461\u2013485. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111518.","DOI":"10.1146\/annurev-biochem-013118-111518"},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"15207","DOI":"10.1038\/s41598-018-33474-z","volume":"8","author":"OR Brekk","year":"2018","unstructured":"Brekk OR, Moskites A, Isacson O, Hallett PJ (2018) Lipid-dependent deposition of alpha-synuclein and tau on neuronal Secretogranin II-positive vesicular membranes with age. Sci Rep 8:15207. https:\/\/doi.org\/10.1038\/s41598-018-33474-z","journal-title":"Sci Rep"},{"key":"1004_CR8","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1073\/pnas.0603765103","volume":"103","author":"MB Cachon-Gonzalez","year":"2006","unstructured":"Cachon-Gonzalez MB, Wang SZ, Lynch A, Ziegler R, Cheng SH, Cox TM (2006) Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci 103:10373\u201310378. https:\/\/doi.org\/10.1073\/pnas.0603765103","journal-title":"Proc Natl Acad Sci"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/hmg\/ddt459","volume":"23","author":"M-B Cach\u00f3n-Gonz\u00e1lez","year":"2014","unstructured":"Cach\u00f3n-Gonz\u00e1lez M-B, Wang SZ, Ziegler R, Cheng SH, Cox TM (2014) Reversibility of neuropathology in Tay\u2013Sachs-related diseases. Hum Mol Genet 23:730\u2013748. https:\/\/doi.org\/10.1093\/hmg\/ddt459","journal-title":"Hum Mol Genet"},{"key":"1004_CR10","doi-asserted-by":"publisher","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV \u03b1-Synucleinopathy. J Neurosci 29:3365\u201373. https:\/\/doi.org\/10.1523\/JNEUROSCI.5427-08.2009","DOI":"10.1523\/JNEUROSCI.5427-08.2009"},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jmb.2011.03.009","volume":"408","author":"J Fantini","year":"2011","unstructured":"Fantini J, Yahi N (2011) Molecular basis for the Glycosphingolipid-binding specificity of \u03b1-Synuclein: key role of tyrosine 39 in membrane insertion. J Mol Biol 408:654\u2013669. https:\/\/doi.org\/10.1016\/j.jmb.2011.03.009","journal-title":"J Mol Biol"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of \u03b1-Synuclein. J Neurosci 24:6715\u20136723. https:\/\/doi.org\/10.1523\/JNEUROSCI.1594-04.2004","journal-title":"J Neurosci"},{"key":"1004_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.bbapap.2018.07.004","volume":"1866","author":"R Gaspar","year":"2018","unstructured":"Gaspar R, Pallbo J, Weininger U, Linse S, Sparr E (2018) Ganglioside lipids accelerate \u03b1-synuclein amyloid formation. Biochim Biophys Acta, Proteins Proteomics 1866:1062\u20131072. https:\/\/doi.org\/10.1016\/j.bbapap.2018.07.004","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/10409239009090616","volume":"25","author":"GA Grabowski","year":"1990","unstructured":"Grabowski GA, Gaft S, Horowitz M, Kolodny EH (1990) Acid \u03b2-Glucosidase: enzymology and molecular biology of Gaucher Diseas. Crit Rev Biochem Mol Biol 25:385\u2013414. https:\/\/doi.org\/10.3109\/10409239009090616","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1004_CR15","doi-asserted-by":"publisher","unstructured":"Gundersen HJG, Jensen EBV, Kieu K, Nielsen J (1999) The efficiency of systematic sampling in stereology\u2014reconsidered. J Microsc 193:199\u2013211. https:\/\/doi.org\/10.1046\/j.1365-2818.1999.00457.x.","DOI":"10.1046\/j.1365-2818.1999.00457.x"},{"key":"1004_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12974-019-1532-2","volume":"16","author":"PJ Hallett","year":"2019","unstructured":"Hallett PJ, Engelender S, Isacson O (2019) Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson\u2019s disease. J Neuroinflammation 16:153. https:\/\/doi.org\/10.1186\/s12974-019-1532-2","journal-title":"J Neuroinflammation"},{"key":"1004_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","volume":"14","author":"M Huebecker","year":"2019","unstructured":"Huebecker M, Moloney EB, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM (2019) Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease. Mol Neurodegener 14:40. https:\/\/doi.org\/10.1186\/s13024-019-0339-z","journal-title":"Mol Neurodegener"},{"key":"1004_CR18","doi-asserted-by":"publisher","unstructured":"Ip CW, Cheong D, Volkmann J (2017) Stereological estimation of dopaminergic neuron number in the mouse Substantia Nigra using the optical fractionator and standard microscopy equipment. J Vis Exp 56103. https:\/\/doi.org\/10.3791\/56103","DOI":"10.3791\/56103"},{"key":"1004_CR19","doi-asserted-by":"publisher","unstructured":"Isacson O, Brekk OR, Hallett PJ (2019) Novel results and concepts emerging from lipid cell biology relevant to degenerative brain aging and disease. Front Neurol 10:1053. https:\/\/doi.org\/10.3389\/fneur.2019.01053","DOI":"10.3389\/fneur.2019.01053"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1471-4159.2008.05776.x","volume":"108","author":"E Israeli","year":"2009","unstructured":"Israeli E, Sharon R (2009) \u03b2-Synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with \u03b1-synuclein. J Neurochem 108:465\u2013474. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05776.x","journal-title":"J Neurochem"},{"key":"1004_CR21","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bj\u00f6rklund A (2002) Parkinson-like Neurodegeneration induced by targeted overexpression of \u03b1-Synuclein in the Nigrostriatal system. J Neurosci 22:2780\u20132791. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-07-02780.2002","journal-title":"J Neurosci"},{"key":"1004_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017698","volume":"6","author":"JB Koprich","year":"2011","unstructured":"Koprich JB, Johnston TH, Huot P, Reyes MG, Espinosa M, Brotchie JM (2011) Progressive Neurodegeneration or endogenous compensation in an animal model of Parkinson\u2019s disease produced by decreasing doses of alpha-Synuclein. PLoS One 6:e17698. https:\/\/doi.org\/10.1371\/journal.pone.0017698","journal-title":"PLoS One"},{"key":"1004_CR23","doi-asserted-by":"publisher","unstructured":"Korecka J, Schouten M, Eggers R, Ulusoy A, Bossers K, Verhaagen J (2011) Comparison of AAV serotypes for gene delivery to dopaminergic neurons in the Substantia Nigra. Viral Gene Ther. https:\/\/doi.org\/10.5772\/18939","DOI":"10.5772\/18939"},{"key":"1004_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nm0496-424","volume":"2","author":"HD Lacorazza","year":"1996","unstructured":"Lacorazza HD, Flax JD, Snyder EY, Jendoubi M (1996) Expression of human \u03b2\u2013hexosaminidase \u03b1\u2013subunit gene (the gene defect of Tay\u2013Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med 2:424\u2013429. https:\/\/doi.org\/10.1038\/nm0496-424","journal-title":"Nat Med"},{"key":"1004_CR25","doi-asserted-by":"crossref","unstructured":"Ledeen RW, Wu G (2018) Chapter fifteen - Gangliosides, \u03b1-Synuclein, and Parkinson\u2019s disease. In: Schnaar RL, Lopez PHH (eds) Progress in Molecular Biology and Translational Science. Academic Press, pp. 435\u2013454","DOI":"10.1016\/bs.pmbts.2017.12.009"},{"key":"1004_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2018-318650","volume":"90","author":"S Licher","year":"2019","unstructured":"Licher S, Darweesh SKL, Wolters FJ, Fani L, Heshmatollah A, Mutlu U, Koudstaal PJ, Heeringa J, Leening MJG, Ikram MK, Ikram MA (2019) Lifetime risk of common neurological diseases in the elderly population. J Neurol Neurosurg Psychiatry 90:148\u2013156. https:\/\/doi.org\/10.1136\/jnnp-2018-318650","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1004_CR27","doi-asserted-by":"publisher","unstructured":"Martinez Z, Zhu M, Han S, Fink AL (2007) GM1 specifically interacts with \u03b1-Synuclein and inhibits fibrillation. Biochemistry 46:1868\u201377. https:\/\/doi.org\/10.1021\/bi061749a","DOI":"10.1021\/bi061749a"},{"key":"1004_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","volume":"56","author":"TE Moors","year":"2019","unstructured":"Moors TE, Paciotti S, Ingrassia A, Quadri M, Breedveld G, Tasegian A, Chiasserini D, Eusebi P, Duran-Pacheco G, Kremer T, Calabresi P, Bonifati V, Parnetti L, Beccari T, van de Berg WDJ (2019) Characterization of brain Lysosomal activities in GBA-related and sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Mol Neurobiol 56:1344\u20131355. https:\/\/doi.org\/10.1007\/s12035-018-1090-0","journal-title":"Mol Neurobiol"},{"key":"1004_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","volume":"331","author":"DCA Neville","year":"2004","unstructured":"Neville DCA, Coquard V, Priestman DA, te Vruchte DJM, Sillence DJ, Dwek RA, Platt FM, Butters TD (2004) Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal Biochem 331:275\u2013282. https:\/\/doi.org\/10.1016\/j.ab.2004.03.051","journal-title":"Anal Biochem"},{"key":"1004_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2011.02.071","volume":"406","author":"K Niimi","year":"2011","unstructured":"Niimi K, Nishioka C, Miyamoto T, Takahashi E, Miyoshi I, Itakura C, Yamashita T (2011) Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice. Biochem Biophys Res Commun 406:524\u2013528. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.071","journal-title":"Biochem Biophys Res Commun"},{"key":"1004_CR31","doi-asserted-by":"publisher","first-page":"e98906","DOI":"10.1371\/journal.pone.0098906","volume":"9","author":"GS N\u00fcbling","year":"2014","unstructured":"N\u00fcbling GS, Levin J, Bader B, Lorenzl S, Hillmer A, H\u00f6gen T, Kamp F, Giese A (2014) Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-Synuclein oligomers. PLoS One 9:e98906. https:\/\/doi.org\/10.1371\/journal.pone.0098906","journal-title":"PLoS One"},{"key":"1004_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","volume":"66","author":"G Parenti","year":"2015","unstructured":"Parenti G, Andria G, Ballabio A (2015) Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med 66:471\u2013486. https:\/\/doi.org\/10.1146\/annurev-med-122313-085916","journal-title":"Annu Rev Med"},{"key":"1004_CR33","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/j.1471-4159.2008.05268.x","volume":"105","author":"XA Perez","year":"2008","unstructured":"Perez XA, Parameswaran N, Huang LZ, O\u2019Leary KT, Quik M (2008) Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates. J Neurochem 105:1861\u20131872. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05268.x","journal-title":"J Neurochem"},{"key":"1004_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature13476","volume":"510","author":"FM Platt","year":"2014","unstructured":"Platt FM (2014) Sphingolipid lysosomal storage disorders. Nature 510:68\u201375. https:\/\/doi.org\/10.1038\/nature13476","journal-title":"Nature"},{"key":"1004_CR35","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE (2017) Parkinson disease. Nat Rev Dis Primer 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primer"},{"key":"1004_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0076-6","volume":"5","author":"RH Reynolds","year":"2019","unstructured":"Reynolds RH, Bot\u00eda J, Nalls MA, Hardy J, Taliun SAG, Ryten M (2019) Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. Npj Park Dis 5:1\u201314. https:\/\/doi.org\/10.1038\/s41531-019-0076-6","journal-title":"Npj Park Dis"},{"key":"1004_CR37","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/brain\/awx285","volume":"140","author":"LA Robak","year":"2017","unstructured":"Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J, Heutink P, Shulman JM, International Parkinson\u2019s Disease Genomics Consortium (IPDGC), Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin U-M, Saad M, Sim\u00f3n-S\u00e1nchez J, Schulte C, Lesage S, Sveinbj\u00f6rnsd\u00f3ttir S, Arepalli S, Barker R, Ben- Y, Berendse HW, Berg D, Bhatia K, RMA d B, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Bras JM, Brockmann K, Brooks J, Burn DJ, Majounie E, Charlesworth G, Lungu C, Chen H, Chinnery PF, Chong S, Clarke CE, Cookson MR, Mark Cooper J, Corvol JC, Counsell C, Damier P, Dartigues J-F, Deloukas P, Deuschl G, Dexter DT, van Dijk KD, Dillman A, Durif F, D\u00fcrr A, Edkins S, Evans JR, Foltynie T, Dong J, Gardner M, Raphael Gibbs J, Goate A, Gray E, Guerreiro R, Harris C, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang X, Wurster I, M\u00e4tzler W, Hudson G, Hunt SE, Huttenlocher J, Illig T, J\u00f3nsson PV, Lambert J-C, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, Lungu C, McNeill A, Moorby C, Moore M, Morris HR, Morrison KE, Escott-Price V, Mudanohwo E, O\u2019Sullivan SS, Pearson J, Perlmutter JS, P\u00e9tursson H, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Shulman J, Sidransky E, Smith C, CCA S, Stef\u00e1nsson H, Bettella F, Stockton JD, Strange A, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Velseboer D, Vidailhet M, Walker R, van de Warrenburg B, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Stef\u00e1nsson K, Martinez M, Wood NW, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB (2017) Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease. Brain 140:3191\u20133203. https:\/\/doi.org\/10.1093\/brain\/awx285","journal-title":"Brain"},{"key":"1004_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Brown E, Hallett P, Isacson O (2015) Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease. Ann Clin Transl Neurol 2:433\u2013438. https:\/\/doi.org\/10.1002\/acn3.177","journal-title":"Ann Clin Transl Neurol"},{"key":"1004_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2015.6307","volume":"23","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Graham A-R, Brown E, McLean JR, Hayes MA, Beagan J, Izen SC, Perez-Torres E, Hallett PJ, Isacson O (2015) Sustained systemic Glucocerebrosidase inhibition induces brain \u03b1-Synuclein aggregation, microglia and complement C1q activation in mice. Antioxid Redox Signal 23:550\u2013564. https:\/\/doi.org\/10.1089\/ars.2015.6307","journal-title":"Antioxid Redox Signal"},{"key":"1004_CR40","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","volume":"33","author":"K Sandhoff","year":"2013","unstructured":"Sandhoff K, Harzer K (2013) Gangliosides and Gangliosidoses: principles of molecular and metabolic pathogenesis. J Neurosci 33:10195\u201310208. https:\/\/doi.org\/10.1523\/JNEUROSCI.0822-13.2013","journal-title":"J Neurosci"},{"key":"1004_CR41","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","volume":"18","author":"K Sandhoff","year":"1971","unstructured":"Sandhoff K, Harzer K, W\u00e4ssle W, Jatzkewitz H (1971) Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem 18:2469\u20132489. https:\/\/doi.org\/10.1111\/j.1471-4159.1971.tb00204.x","journal-title":"J Neurochem"},{"key":"1004_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K Sango","year":"1995","unstructured":"Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL (1995) Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11:170\u2013176. https:\/\/doi.org\/10.1038\/ng1095-170","journal-title":"Nat Genet"},{"key":"1004_CR43","doi-asserted-by":"publisher","first-page":"e0199189","DOI":"10.1371\/journal.pone.0199189","volume":"13","author":"JS Schneider","year":"2018","unstructured":"Schneider JS (2018) Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson\u2019s disease. PLoS One 13:e0199189. https:\/\/doi.org\/10.1371\/journal.pone.0199189","journal-title":"PLoS One"},{"key":"1004_CR44","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Casta\u00f1o-D\u00edez D, Schweighauser G, Graff-Meyer A, Goldie KN, S\u00fctterlin R, Huisman E, Ingrassia A, de Gier Y, Rozemuller AJM, Wang J, Paepe AD, Erny J, Staempfli A, Hoernschemeyer J, Gro\u00dfer\u00fcschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, IJcken WFJV, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, de Berg WDJV, Lauer ME (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22:1099. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","journal-title":"Nat Neurosci"},{"key":"1004_CR45","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) \u03b1-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci U S A 98:9110\u20139115. https:\/\/doi.org\/10.1073\/pnas.171300598","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1004_CR46","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen C-M, Clark LN, Condroyer C, De Marco EV, D\u00fcrr A, Eblan MJ, Fahn S, Farrer MJ, Fung H-C, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen G-J, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan E-K, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu Y-R, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of Glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661. https:\/\/doi.org\/10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"key":"1004_CR47","doi-asserted-by":"publisher","unstructured":"Mauri L, Sonnino S, Prinetti A (2018) Chemical and Physicochemical Properties of Gangliosides. Methods Mol Biol 1804:1\u201317. https:\/\/doi.org\/10.1007\/978-1-4939-8552-4_1.","DOI":"10.1007\/978-1-4939-8552-4_1"},{"key":"1004_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-007-0264-z","volume":"114","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Iseki E, Togo T, Yamaguchi A, Katsuse O, Katsuyama K, Kanzaki S, Shiozaki K, Kawanishi C, Yamashita S, Tanaka Y, Yamanaka S, Hirayasu Y (2007) Neuronal and glial accumulation of \u03b1- and \u03b2-synucleins in human lipidoses. Acta Neuropathol (Berl) 114:481\u2013489. https:\/\/doi.org\/10.1007\/s00401-007-0264-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"1004_CR49","doi-asserted-by":"publisher","unstructured":"Suzuki K, Yamaguchi A, Yamanaka S, Kanzaki S, Kawashima M, Togo T, Katsuse O, Koumitsu N, Aoki N, Iseki E, Kosaka K, Yamaguchi K, Hashimoto M, Aoki I, Hirayasu Y (2016) Accumulated \u03b1-synuclein affects the progression of GM2 gangliosidoses. Exp Neurol 284, part a:38\u201349. https:\/\/doi.org\/10.1016\/j.expneurol.2016.07.011","DOI":"10.1016\/j.expneurol.2016.07.011"},{"key":"1004_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.expneurol.2007.09.011","volume":"209","author":"A Ulusoy","year":"2008","unstructured":"Ulusoy A, Bjorklund T, Hermening S, Kirik D (2008) In vivo gene delivery for development of mammalian models for Parkinson\u2019s disease. Exp Neurol 209:89\u2013100. https:\/\/doi.org\/10.1016\/j.expneurol.2007.09.011","journal-title":"Exp Neurol"},{"key":"1004_CR51","doi-asserted-by":"publisher","unstructured":"Wendeler M, Sandhoff K (2009) Hexosaminidase assays. Glycoconj J N Y 26:945\u201352. https:\/\/doi.org\/10.1007\/s10719-008-9137-5.","DOI":"10.1007\/s10719-008-9137-5"},{"key":"1004_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK, Morrison A, Lwin A, Colegial C, Allman JM, Schiffmann R (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82:192\u2013207. https:\/\/doi.org\/10.1016\/j.ymgme.2004.04.011","journal-title":"Mol Genet Metab"},{"key":"1004_CR53","doi-asserted-by":"publisher","unstructured":"Wu G, Lu Z-H, Kulkarni N, Amin R, Ledeen RW (2011) Mice lacking major brain Gangliosides develop parkinsonism. Neurochem Res 36(9):1706-14. https:\/\/doi.org\/10.1007\/s11064-011-0437-y..","DOI":"10.1007\/s11064-011-0437-y."},{"key":"1004_CR54","doi-asserted-by":"publisher","unstructured":"Xilouri M, Brekk OR, Landeck N, Pitychoutis PM, Papasilekas T, Papadopoulou-Daifoti Z, Kirik D, Stefanis L (2013) Boosting chaperone-mediated autophagy in vivo mitigates \u03b1-synuclein-induced neurodegeneration. Brain 136:2130\u201346. https:\/\/doi.org\/10.1093\/brain\/awt131","DOI":"10.1093\/brain\/awt131"},{"key":"1004_CR55","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1073\/pnas.0903279106","volume":"106","author":"M Yoshikawa","year":"2009","unstructured":"Yoshikawa M, Go S, Takasaki K, Kakazu Y, Ohashi M, Nagafuku M, Kabayama K, Sekimoto J, Suzuki S, Takaiwa K, Kimitsuki T, Matsumoto N, Komune S, Kamei D, Saito M, Fujiwara M, Iwasaki K, Inokuchi J (2009) Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc Natl Acad Sci 106:9483\u20139488. https:\/\/doi.org\/10.1073\/pnas.0903279106","journal-title":"Proc Natl Acad Sci"},{"key":"1004_CR56","doi-asserted-by":"publisher","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 2019;18(12):1091-102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5.","DOI":"10.1016\/S1474-4422(19)30320-5"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-01004-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T23:21:38Z","timestamp":1628205698000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-01004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-01004-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}